5 FAQs about Class Actions Lawsuits in Ohio
Posted in: Class Actions
Our Ohio attorneys are here for you and your family.
Elmiron is a prescription drug manufactured by Janssen Pharmaceuticals to treat interstitial cystitis (IC), known as “painful bladder syndrome.” Unfortunately, there is reason to believe that Elmiron may also cause the serious eye condition – pigmentary maculopathy, which leads to vision loss and possible blindness.
The dangers associated with Elmiron (pentosan polysulfate sodium) came to light in 2015 when several women with mysterious eye problems discovered they had all taken Elmiron. Afterward, the risks became apparent, with severe ocular damage frequently occurring in those who used Elmiron for six months or longer. As more evidence was uncovered, it now appears that Janssen Pharmaceuticals failed to warn the public of these risks, possibly robbing countless people of their sight.
Various lawsuits are currently being pursued against those responsible. So, if you or a loved one developed pigmentary maculopathy as a result of taking Elmiron, you may have a right to financial compensation. Contact Kisling, Nestico & Redick today. We will explain your options and fight for everything you deserve.
Thousands in the U.S. take Elmiron every day to treat interstitial cystitis. It’s estimated that 25% of them could suffer from pigmentary maculopathy.
Despite the danger, Elmiron is still on the market as of 2020, and pigmentary maculopathy is not listed as a side effect. Also, the longer Elmiron is taken, the greater the risk of ocular damage, vision loss, or blindness due to drug toxicity.
To make matters worse, pigmentary maculopathy is often misdiagnosed by medical professionals. Since most patients taking Elmiron are older, ocular damage is typically thought to be an age-related eye condition.
The main distinction between pigmentary maculopathy and other eye problems is the macula’s degeneration–the retina’s central part. These dark spots are how eye doctors identify the condition.
Ophthalmologists recommend that anyone taking Elmiron for more than 6 months should have regular eye exams and cease use if damage is discovered. It’s critical to catch effects early because vision loss could be unavoidable.
No two cases are the same, but you deserve the chance to recover financially from your losses.
A potential recovery from a legal claim or lawsuit connected to retinal maculopathy or blindness related to Elmiron may include your past & future medical expenses, lost income, pain & suffering, mental anguish, punitive damages, and wrongful death damages.
If you or a loved one took Elmiron for 6 months or longer and developed maculopathy, let KNR assess your damages and eligibility for compensation. With our experience and resources, we can help secure what you’re entitled to without risk or up-front cost.